Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis is a research paper published in The Journal of Experimental Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: R01-AI114780
National Institute of Allergy and Infectious Diseases
Grant: R21-AI142198
National Institutes of Health
Grant: U54-NS115054
Muscular Dystrophy Association
Grant: MDA575198
Onassis Foundation
Grant: R ZO 006/2018-2019
NINDS NIH HHS
Grant: U54 NS115054
NCATS NIH HHS
Grant: UL1 TR001863
NIAID NIH HHS
Grant: R01 AI114780
NIAID NIH HHS
Grant: R21 AI142198
NINDS NIH HHS
Grant: R37 NS036193
National Institutes of Health
Grant: 5R21AI142198-02
Novel Approaches for Investigating the Pathology of Myasthenia Gravis Autoantibodies
National Institutes of Health
Grant: 5R01AI114780-04
Mechanisms of autoantibody production in myasthenia gravis
National Institutes of Health
Grant: 5U54NS115054-03
Rare Disease Network for Myasthenia Gravis
Colton Center for Autoimmunity
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals